Pharmamarketeer

Harmony Biosciences gets US FDA approval for Wakix for treatment of excessive daytime sleepiness in adult with narcolepsy

Harmony Biosciences, LLC, a private biopharmaceutical company, announced that the US Food and Drug Administration (FDA) approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.

Medhc-fases-banner
Advertentie(s)